Eyes

Published human studies of carnosine and N-acetylcarnosine in the eye, mostly as eye drops for cataract, and the independent reviews of that work.

This page lists published studies. It reports what the authors did and found, with the limits of each study. It is not advice.

5 studies listed, newest first.

• N-acetylcarnosine (NAC) drops for age-related cataract
  Dubois VD et al. · Cochrane Database of Systematic Reviews · 2017
  ReviewHumansWith N-acetylcarnosine (carnosine prodrug) eye drops
• Physiology and pathophysiology of carnosine
  Boldyrev AA et al. · Physiological Reviews · 2013
  ReviewHumansOther animals
• N-acetylcarnosine lubricant eyedrops possess all-in-one universal antioxidant protective effects of L-carnosine in aqueous and lipid membrane environments, aldehyde scavenging, and transglycation activities inherent to cataracts: a clinical study of the new vision-saving drug N-acetylcarnosine eyedrop therapy in a database population of over 50,500 patients
  Babizhayev MA et al. · American Journal of Therapeutics · 2009
  Controlled trialHumansTopicalWith N-acetylcarnosine (carnosine prodrug) eyedrops
• Efficacy of N-Acetylcarnosine in the Treatment of Cataracts
  Babizhayev MA et al. · Drugs in R&D · 2002
  Randomised controlled trialHumansTopicalWith N-acetylcarnosine (carnosine prodrug) 1% eye drops
• N-Acetylcarnosine, a natural histidine-containing dipeptide, as a potent ophthalmic drug in treatment of human cataracts
  Babizhayev MA et al. · Peptides · 2001
  Controlled trialHumansTopicalWith N-acetylcarnosine (carnosine prodrug)